| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.006 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.4 | 0.007 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.007 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.17 | 0.007 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.078 | 0.008 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.008 |